Indoco Remedies Ltd Financial Statement
*All values are in Rs. Cr
| Particulars | Jun 2025 | Mar 2025 | Dec 2024 |
|---|---|---|---|
| Revenue | 398.11 | 353.75 | 378.23 |
| Operating Expense | 377.70 | 343.79 | 352.84 |
| Net Profit | -28.06 | -26.24 | -10.23 |
| Net Profit Margin | -7.05 | -7.42 | -2.70 |
| Earning Per Share | -3.04 | -2.85 | -1.11 |
| EBIDTA | 20.75 | 11.69 | 23.48 |
| Effective Tax Rate | TBA | -29.42 | -19.85 |
| Particulars | Jun 2025 |
|---|---|
| Revenue | 398.11 |
| Operating Expense | 377.70 |
| Net Profit | -28.06 |
| Net Profit Margin | -7.05 |
| Earning Per Share | -3.04 |
| EBIDTA | 20.75 |
| Effective Tax Rate | TBA |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|
| Total Revenue Annual | 1,518.19 | 1,790.81 | 1,666.69 |
| Operating Expenses Annual | 1,390.16 | 1,532.82 | 1,381.80 |
| Operating Profit Annual | 147.51 | 278.02 | 287.22 |
| Interest Annual | 56.63 | 36.81 | 25.03 |
| Depreciation | 62.36 | 57.94 | 54.41 |
| Net Profit Annual | -8.74 | 116.64 | 141.36 |
| Tax Annual | 1.36 | 36.58 | 50.23 |
| Particulars | Mar 2025 |
|---|---|
| Total Revenue Annual | 1,518.19 |
| Operating Expenses Annual | 1,390.16 |
| Operating Profit Annual | 147.51 |
| Interest Annual | 56.63 |
| Depreciation | 62.36 |
| Net Profit Annual | -8.74 |
| Tax Annual | 1.36 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|
| Cash Flow at the Beginning | 7.47 | 9.99 | 16.90 |
| Cash Flow from Operations | 90.77 | 176.78 | 178.79 |
| Cash Flow from Investing | -259.79 | -301.70 | -208.51 |
| Cash Flow from Financing | 168.62 | 122.40 | 22.81 |
| Cash Flow at the End | 7.06 | 7.47 | 9.99 |
| Particulars | Mar 2025 |
|---|---|
| Cash Flow at the Beginning | 7.47 |
| Cash Flow from Operations | 90.77 |
| Cash Flow from Investing | -259.79 |
| Cash Flow from Financing | 168.62 |
| Cash Flow at the End | 7.06 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|
| PBDIT Margin (%) | 9.64 | 15.52 | 17.23 |
| PBIT Margin (%) | 3.17 | 10.61 | 13 |
| PBT Margin (%) | 3.11 | 10.32 | 12.48 |
| Net PROFIT Margin (%) | -0.58 | 6.51 | 8.48 |
| Return On Networth / Equity (%) | -0.89 | 10.83 | 14.64 |
| Return On Networth /Employed (%) | 2.68 | 12.31 | 16.66 |
| Return On Assets (%) | -0.49 | 7.56 | 10.86 |
| Total Debt / Equity (X) | 0.57 | 0.39 | 0.31 |
| Asset Turnover Ratio (%) | 0.85 | 1.16 | 1.28 |
| Particulars | Mar 2025 |
|---|---|
| PBDIT Margin (%) | 9.64 |
| PBIT Margin (%) | 3.17 |
| PBT Margin (%) | 3.11 |
| Net PROFIT Margin (%) | -0.58 |
| Return On Networth / Equity (%) | -0.89 |
| Return On Networth /Employed (%) | 2.68 |
| Return On Assets (%) | -0.49 |
| Total Debt / Equity (X) | 0.57 |
| Asset Turnover Ratio (%) | 0.85 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|
| Fixed Assets Annual | 798.80 | 754.28 | 719.66 |
| Total Current Assets Annual | 955.47 | 900.21 | 812.47 |
| Non Current Assets Annual | 1,245.69 | 1,060.39 | 847.21 |
| Total Shareholders Funds Annual | 1,103.36 | 1,126.62 | 1,027.02 |
| Total Assets Annual | 2,201.16 | 1,960.61 | 1,659.67 |
| Particulars | Mar 2025 |
|---|---|
| Fixed Assets Annual | 798.80 |
| Total Current Assets Annual | 955.47 |
| Non Current Assets Annual | 1,245.69 |
| Total Shareholders Funds Annual | 1,103.36 |
| Total Assets Annual | 2,201.16 |
EPS (INR)
Expected
0.00
Reported
-3.94
Surprise
0.00%
Mar 2025
EPS beaten by 0.00%
Dec 2024
EPS beaten by 0.00%
Sep 2024
EPS beaten by 0.00%
